Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Number of holders
-
625
-
Total 13F shares, excl. options
-
52,958,336
-
Shares change
-
+1,355,665
-
Total reported value, excl. options
-
$9,771,240,814
-
Value change
-
+$238,492,914
-
Put/Call ratio
-
196%
-
Number of buys
-
241
-
Number of sells
-
355
-
Price
-
$184.60
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q4 2024
As of 31 Dec 2024 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) had 625 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,958,336 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Allspring Global Investments Holdings, LLC, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Impactive Capital LP, Meritage Group LP, and ARIEL INVESTMENTS, LLC.
This table shows 629 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.